Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.

CONCLUSIONS: Our results suggest that the value of PD-L1 mRNA in prognosticating outcome in lung cancer is limited. Further studies are needed to identify novel prognostic biomarkers other than PD-L1 that are associated with improved patient survival. Identification of further prognostically important biomarkers may prove useful in identifying patients suitable for immunotherapy.
PMID: 29510096 [PubMed - as supplied by publisher]

Source: The Annals of Thoracic Surgery - March 3, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Sepesi B, Nelson DB, Mitchell KG, Gibbons DL, Heymach JV, Vaporciyan AA, Swisher SG, Roszik J Tags: Ann Thorac Surg Source Type: research